The Texas-based specialty infusion provider has been growing at a more than 20% clip year-over-year.
2 min read · 04 September 2020
GHO Capital agrees to buy Ardian’s stake in UK's Envision Pharma Group.
3 min read · 03 September 2020
Paris-based Ardian and London-based GHO jointly acquired Envision in July 2016 from the Halifax Group, with the former assuming a majority stake.
2 min read · 03 September 2020
The firm is also considering exploring a secondaries continuation vehicle for two existing Fund III portfolio companies.
3 min read · 01 September 2020
Blackstone invests in Cryoport causing the latter's stock to soar and Levine Leichtman acquires BigHand from Bridgepoint Development.
2 min read · 31 August 2020
For Blackstone, investing in Cryoport offers a means to ride the rapid and sustained growth of cell and gene therapy without taking on direct idiosyncratic risk.
4 min read · 28 August 2020
Concluding an Edgemont Partners sale process, the European suitor emerges with a deal that leaves management with an approximately 20% stake in the medical device services company.
3 min read · 27 August 2020
Blackstone Tactical Opportunities will be investing $275 million in Cryoport to support two new acquisitions in the cell and gene therapy supply chain.
3 min read · 27 August 2020
Erlanger Health System rebuffs StoneBridge's $425 million bid to acquire Erlanger Health Systems and Venn Growth expands its team while preparing to roll out a $300 million inaugural fund.
2 min read · 27 August 2020
If passed, SB 977 would give the California attorney general never-before-seen authority over healthcare consolidation, but not every buyer is included and there could be ways for PE firms to circumvent the law, lawyers said.
7 min read · 27 August 2020
